NCT01420809View on ClinicalTrials.gov

Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection

CompletedOBSERVATIONAL
Enrollment

1,280

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

August 31, 2009

Conditions
Thromboembolism
Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY